Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06904534 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Aug 30, 2025 to Nov 30, 2025v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The potential unexpected effects of nifedipine and MgSO4, the tocolytic agents used for the indication of preterm labor, on fetal heart will be determined. In this study, the fetal echocardiographic findings of nifedipine and MgSO4 will be compared.
Trial Details
NCT Number NCT06904534
Lead Sponsor Sanliurfa Education and Research Hospital
Conditions
(from sponsor)		 Unexpected Fetal Cardiac Effects of Nifedipine and MgSO4
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov